Twist Bioscience Corporation (TWST) Identifies Competitive Antibodies for SARS-CoV-2

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Twist Bioscience Corporation (TWST) Identifies Competitive Antibodies for SARS-CoV-2

Twist Bioscience Identifies Competitive Antibodies for SARS-CoV-2

May 6, 2020 8:00 AM EDT

Functional Antibodies Identified to S1 Spike Protein and ACE2 Cellular Receptor

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Twist Bioscience Corporation (Nasdaq: TWST) today reported it has identified competitive antibodies to SARS-CoV-2, the virus that causes COVID-19, which could potentially be used for diagnostic tests or therapeutic treatments. Twists unique monoclonal antibody candidates bind with high affinity to the receptor binding domain (RBD) on the S1 spike protein on the surface of SARS-CoV-2 viral molecules. Twist has also found antibody candidates that bind with high affinity... More